Paul Hartmann AG - SWOT, Strategy and Corporate Finance Report

Table of Contents

Related Reports

50 Results found for "Related Reports"

Report Title	Report Type	Country	Published	Price
KC BioMediX, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report	Company Profile	Global	12 June 2013	£222.85
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...			More Info Add to Wishlist
rEVO Biologics - Product Pipeline Review - 2013	Company Profile	Global	6 June 2013	£955.09
The pharmaceuticals report, "rEVO Biologics - Product Pipeline Review - 2013" provides data on the rEVO Biologics's research and development focus. The report includes information on curr...			More Info Add to Wishlist
Regeneron Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Regeneron Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.<br ...			More Info Add to Wishlist
Isis Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Isis Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.<b...			More Info Add to Wishlist
Genmab Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Genmab 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.This repor...			More Info Add to Wishlist
Ranbaxy Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Ranbaxy 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This repor...			More Info Add to Wishlist
PDL BioPharma Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with PDL BioPharma 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This...			More Info Add to Wishlist
Emergent BioSolutions Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Emergent BioSolutions 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.<...			More Info Add to Wishlist
Onyx Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Onyx Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.<br...			More Info Add to Wishlist
Cangene Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Cangene 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.This repo...			More Info Add to Wishlist
NPS Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with NPS Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.<br...			More Info Add to Wishlist
Enzon Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Enzon Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.<...			More Info Add to Wishlist
BioCryst Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with BioCryst Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.<br ...			More Info Add to Wishlist
Vertex Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Vertex 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This report...			More Info Add to Wishlist
Alexion Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Alexion Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies....			More Info Add to Wishlist
Cubist Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Cubist 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This report...			More Info Add to Wishlist
Fresenius Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Fresenius 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This rep...			More Info Add to Wishlist
United Therapeutics Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with United Therapeutics 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.<br ...			More Info Add to Wishlist
Amylin Pharmaceuticals Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Amylin Pharmaceuticals 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.<...			More Info Add to Wishlist
Viropharma Partnering 2005-2013	Company Profile	Global	1 June 2013	£633.54
The Partnering Agreements with Viropharma 2005-2013 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.This re...			More Info Add to Wishlist

111.43

Select License Type

£111.43	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£278.57	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£111.43	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Company Profile
Country	Global
Published	1 January 2013
Number of Pages	32
Report Delivery	Email
Delivery Lead Time	1-3 hours, 24 hour max
Publisher	MarketLine

Company Snapshot
- Paul Hartmann AG: Company Overview
- Paul Hartmann AG: Overview and Key Facts
- - Paul Hartmann AG: Overview
- - Paul Hartmann AG: Key Facts
- Paul Hartmann AG: Key Employees
- Paul Hartmann AG: Key Employee Biographies
- Paul Hartmann AG: Major Products and Services
- Paul Hartmann AG: Company History
- Paul Hartmann AG: Management Statement
- Paul Hartmann AG: Locations and Subsidiaries
- Paul Hartmann AG: Key Competitors
Paul Hartmann AG: Company Analysis
- Paul Hartmann AG: Business Description
- Paul Hartmann AG: SWOT Analysis
- - Paul Hartmann AG: SWOT Overview
- - Paul Hartmann AG: Strengths
- - Paul Hartmann AG: Weaknesses
- - Paul Hartmann AG: Opportunities
- - Paul Hartmann AG: Threats
- Paul Hartmann AG: Corporate Financial Deals Activity
- Paul Hartmann AG: Financial Deals Overview
- Paul Hartmann AG: Targets and Partners
- Paul Hartmann AG: Top Deals 2009 - 2013YTD*
- Paul Hartmann AG: Mergers and Acquisitions
- Paul Hartmann AG: Divestments
Appendix
- Contact Us
- Methodology
- Definitions
- About Datamonitor

List of Tables

Table 1: Paul Hartmann AG: Key Facts
Table 2: Paul Hartmann AG: Key Employees
Table 4: Paul Hartmann AG: Key Competitors
Table 5: Paul Hartmann AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Paul Hartmann AG: Targets and Partners
Table 7: Paul Hartmann AG: Top Deals 2009 - 2013YTD*
Table 8: Paul Hartmann AG: M&A Volume and Value Trend (2009 - YTD*2013)
Table 9: Paul Hartmann AG: M&A Activity by Geography (2009 - YTD*2013)
Table 10: Paul Hartmann AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Table 11: Paul Hartmann AG: Divestments by Geography (2009 - YTD*2013)

List of Figures

Figure 1: Paul Hartmann AG: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 2: Paul Hartmann AG: M&A Volume and Value Trend (2009 - YTD*2013)
Figure 3: Paul Hartmann AG: M&A Activity by Geography (2009 - YTD*2013)
Figure 4: Paul Hartmann AG: Divestments Volume and Value Trend (2009 - YTD*2013)
Figure 5: Paul Hartmann AG: Divestments by Geography (2009 - YTD*2013)

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£111.43	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£278.57	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.

£111.43	Add to Wishlist
Change Currency	GBP EURO USD

Change Currency

GBP

EURO

USD

Competitor Tracking

Do you need to track your competitors and customers on a continuous basis? We have the expertise to provide you with a cost-effective, fully customised competitor tracking portal, which collates data on your competitors on a continuous basis. Contact us for a free consultation and demonstration.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website.

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Paul Hartmann AG - SWOT, Strategy and Corporate Finance Report

50 Results found for "Related Reports"

Select License Type

Table of Contents

Speak to an Advisor

Select License Type

Change Currency

Competitor Tracking

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of the Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Republic of the Congo
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel